Cargando…

Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies

The β-hemoglobinopathies sickle cell anemia and β-thalassemia are the focus of many gene-therapy studies. A key disease parameter is the abundance of globin chains because it indicates the level of anemia, likely toxicity of excess or aberrant globins, and therapeutic potential of induced or exogeno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loucari, Constantinos C., Patsali, Petros, van Dijk, Thamar B., Stephanou, Coralea, Papasavva, Panayiota, Zanti, Maria, Kurita, Ryo, Nakamura, Yukio, Christou, Soteroulla, Sitarou, Maria, Philipsen, Sjaak, Lederer, Carsten W., Kleanthous, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806072/ https://www.ncbi.nlm.nih.gov/pubmed/29325430 http://dx.doi.org/10.1089/hgtb.2017.190

Ejemplares similares

Distinct miRNA Signatures and Networks Discern Fetal from Adult Erythroid Differentiation and Primary from Immortalized Erythroid Cells
por: Papasavva, Panayiota L., et al.
Publicado: (2021)

Relative and Absolute Quantification of Aberrant and Normal Splice Variants in HBB(IVSI−110 (G > A)) β-Thalassemia
por: Patsali, Petros, et al.
Publicado: (2020)

CRISPR Editing Enables Consequential Tag-Activated MicroRNA-Mediated Endogene Deactivation
por: Papasavva, Panayiota L., et al.
Publicado: (2022)

High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis
por: Papaioannou, Nikoletta Y., et al.
Publicado: (2023)

IthaPhen: An Interactive Database of Genotype-Phenotype Data for Hemoglobinopathies
por: Xenophontos, Maria, et al.
Publicado: (2023)

Genetic Modifiers at the Crossroads of Personalised Medicine for Haemoglobinopathies
por: Stephanou, Coralea, et al.
Publicado: (2019)

The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements
por: Patsali, Petros, et al.
Publicado: (2019)

PB2515: A PILOT STUDY OF THE INTERNATIONAL HEMOGLOBINOPATHY RESEARCH NETWORK (INHERENT)
por: Kountouris, Petros, et al.
Publicado: (2023)

Adapting the ACMG/AMP variant classification framework: A perspective from the ClinGen Hemoglobinopathy Variant Curation Expert Panel
por: Kountouris, Petros, et al.
Publicado: (2021)

Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases
por: Papasavva, Panayiota, et al.
Publicado: (2019)

Disruptive Technology: CRISPR/Cas-Based Tools and Approaches
por: Patsali, Petros, et al.
Publicado: (2019)

Measurement of lentiviral vector titre and copy number by cross-species duplex quantitative PCR
por: Christodoulou, I, et al.
Publicado: (2016)

P135: THE CLINGEN HEMOGLOBINOPATHY VARIANT CURATION EXPERT PANEL
por: Coralea Stephanou, C, et al.
Publicado: (2022)

Sex-specific transcriptional profiles identified in β-thalassemia patients
por: Nanou, Aikaterini, et al.
Publicado: (2021)

Recent Approaches for Manipulating Globin Gene Expression in Treating Hemoglobinopathies
por: Mussolino, Claudio, et al.
Publicado: (2021)

5′HS5 of the Human β-globin Locus Control Region Is Dispensable for the Formation of the β-globin Active Chromatin Hub
por: Chan, Ping Kei, et al.
Publicado: (2008)

Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies
por: Venkatesan, Vigneshwaran, et al.
Publicado: (2023)

Proteomic Studies for the Investigation of γ-Globin Induction by Decitabine in Human Primary Erythroid Progenitor Cultures
por: Theodorou, Andria, et al.
Publicado: (2020)

A Novel Tool for the Analysis and Detection of Copy Number Variants Associated with Haemoglobinopathies
por: Minaidou, Anna, et al.
Publicado: (2022)

PI-07: THE INTERNATIONAL HEMOGLOBINOPATHY RESEARCH NETWORK (INHERENT): AN INTERNATIONAL INITIATVE TO STUDY THE ROLE OF GENETIC MODIFIERS IN HEMOGLOBINOPATHIES
por: P., KOUNTOURIS, et al.
Publicado: (2022)

Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus
por: Kountouris, Petros, et al.
Publicado: (2020)

P1481: THE INTERNATIONAL HEMOGLOBINOPATHY RESEARCH NETWORK (INHERENT): AN INTERNATIONAL INITIATIVE TO STUDY THE ROLE OF GENETIC MODIFIERS IN HEMOGLOBINOPATHIES
por: Kountouris, P., et al.
Publicado: (2022)

Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing
por: Fontana, Letizia, et al.
Publicado: (2023)

A Dual Reporter Mouse Model of the Human β-Globin Locus: Applications and Limitations
por: Papadopoulos, Petros, et al.
Publicado: (2012)

Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene
por: Negre, Olivier, et al.
Publicado: (2016)

A novel mutation in the erythroid transcription factor KLF1 is likely responsible for ameliorating β‐thalassemia major
por: Fanis, Pavlos, et al.
Publicado: (2019)

Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies
por: Lederer, Carsten W., et al.
Publicado: (2022)

Global Globin Network Consensus Paper: Classification and Stratified Roadmaps for Improved Thalassaemia Care and Prevention in 32 Countries
por: Halim-Fikri, Bin Hashim, et al.
Publicado: (2022)

Mild dyserythropoiesis and β-like globin gene expression imbalance due to the loss of histone chaperone ASF1B
por: Papadopoulos, Petros, et al.
Publicado: (2020)

Hemoglobin switching in mice carrying the Klf1Nan variant
por: Korporaal, Anne, et al.
Publicado: (2020)

The molecular spectrum and distribution of haemoglobinopathies in Cyprus: a 20-year retrospective study
por: Kountouris, Petros, et al.
Publicado: (2016)

Updates in Hemoglobinopathies
por: Al-Tonbary, Youssef, et al.
Publicado: (2013)

Editorial: Mutation-Specific Gene Editing for Blood Disorders
por: Lederer, Carsten Werner, et al.
Publicado: (2021)

P128: ITHANET: AN INFORMATION AND DATABASE COMMUNITY PORTAL FOR HAEMOGLOBINOPATHIES
por: Minaidou, A, et al.
Publicado: (2022)

Prenatal Diagnosis of β-Thalassemias and Hemoglobinopathies.
por: Rosatelli, Maria Cristina, et al.
Publicado: (2009)

The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34(+) Cells from Sickle Cell Disease Patients
por: Drakopoulou, Ekati, et al.
Publicado: (2022)

Gene Therapy for Hemoglobinopathies
por: Cavazzana, Marina, et al.
Publicado: (2018)

Gene Therapy of the Hemoglobinopathies
por: Kunz, Joachim B., et al.
Publicado: (2020)

Hemoglobinopathy and COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Rare Combinational Hemoglobinopathies
por: Husan, Ammar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dp84vh95ppe8s0qnaknbek2gh8